天美影院

Explore our comprehensive portfolio that addresses the complete care continuum for many of the world鈥檚 most threatening diseases. 

Shape 25 Spotlight
Industry trends

Insights
Conferences & events

Discover the stories of pioneers pushing the boundaries of what鈥檚 possible in healthcare to help improve people鈥檚 lives around the world.

Patient-centered innovation has been and always will be at the core of our company. Dive deeper into our fascinating technologies.

We pioneer breakthroughs in healthcare. For everyone. Everywhere. Sustainably. Learn more about our purpose, our innovation leadership, our culture, and our strategy.

  1. Home

  2. Press center
  3. Press releases
  4. Siemens Healthineers again clearly increases revenue and margin in the third quarter
Press release

Siemens Healthineers again clearly increases revenue and margin in the third quarter

Siemens Healthineers AG today announces its results for the third quarter of fiscal year 2025 ended June 30, 2025.
Published on July 30, 2025

Q3 Fiscal Year 2025 

  • Good equipment book-to-bill ratio of 1.09 
  • Very strong comparable revenue growth of 7.6% 
  • Imaging shows excellent comparable revenue growth of 11.7%; adjusted EBIT margin 21.0% 
  • Diagnostics posts slight comparable revenue decline of 0.6%; adjusted EBIT margin 9.2% 
  • Varian comparable revenue growth 8.7%; adjusted EBIT margin 18.8% 
  • Advanced Therapies comparable revenue growth 4.5%; adjusted EBIT margin 10.5% 
  • Overall adjusted EBIT margin 16.8%, clearly above prior-year quarter 
  • Free cash flow up by more than 50% from prior-year quarter to around 鈧840 million 
  • Adjusted basic earnings per share 鈧0.64, clearly above prior-year quarter

Updated Outlook for Fiscal Year 2025

As a result of the latest geopolitical developments, in particular the agreements on trade tariffs, we narrow the ranges for comparable revenue growth and adjusted basic earnings per share in our outlook for fiscal year 2025. We also raise the midpoints of the ranges, mainly due to our performance year to date. We now expect comparable revenue growth of between 5.5% and 6% over fiscal year 2024 (previously between 5% and 6%) and adjusted basic earnings per share of between 鈧2.30 and 鈧2.45 (previously between 鈧2.20 and 鈧2.50). 

Bernd Montag, CEO of Siemens Healthineers AG:

鈥漌e had a very good quarter with high revenue growth, another increase in profitability and strong free cash flow. Therefore we are raising the midpoints of our outlook. While volatility in the geopolitical environment remains high, our performance shows the value of our healthcare innovations for more and more patients around the world.鈥

(pdf, 257.54 KB)

Siemens Healthineers 2025

Siemens Healthineers pioneers breakthroughs in healthcare. For everyone. Everywhere. Sustainably. The company is a global provider of healthcare equipment, solutions and services, with activities in more than 180 countries and direct representation in more than 70. The group comprises Siemens Healthineers AG, listed as SHL in Frankfurt, Germany, and its subsidiaries. As a leading medical technology company, Siemens Healthineers is committed to improving access to healthcare for underserved communities worldwide and is striving to overcome the most threatening diseases. The company is principally active in the areas of imaging, diagnostics, cancer care and minimally invasive therapies, augmented by digital technology and artificial intelligence. In fiscal 2024, which ended on September 30, 2024, Siemens Healthineers had approximately 72,000 employees worldwide and generated revenue of around 鈧22.4 billion. Further information is available at www.siemens-healthineers.com.